CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-31 | Lezack Adam Director | Sale 10b5-1 | −38 | $27.70 | $1K | 9,841 |
| 2025-10-31 | Palasis Maria Director | Sale 10b5-1 | −1,287 | $26.86 | $35K | 9,960 |
| 2025-10-31 | Palasis Maria Director | Sale 10b5-1 | −119 | $27.45 | $3K | 9,841 |
| 2025-10-03 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +4,982 | $5.10 | $25K | 49,023 |
| 2025-10-03 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −3,828 | $21.52 | $82K | 45,195 |
| 2025-10-03 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −1,154 | $22.28 | $26K | 44,041 |
| 2025-10-03 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −4,982 | 69,695 | ||
| 2025-10-01 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +15,018 | $5.10 | $77K | 59,059 |
| 2025-10-01 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −14,918 | $20.76 | $310K | 44,141 |
| 2025-10-01 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −100 | $21.08 | $2K | 44,041 |
| 2025-10-01 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,018 | 74,677 | ||
| 2025-09-08 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +9,900 | $5.10 | $50K | 53,941 |
| 2025-09-08 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −9,900 | $21.13 | $209K | 44,041 |
| 2025-09-08 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −9,900 | 89,695 | ||
| 2025-09-05 | Hopman Mark Chief Commercial Officer | Option exercise 10b5-1 | +11,411 | $5.10 | $58K | 42,626 |
| 2025-09-05 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −11,411 | $20.56 | $235K | 31,215 |
| 2025-09-05 | Hopman Mark Chief Commercial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −11,411 | 21,725 | ||
| 2025-09-05 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +100 | $5.10 | $510 | 44,141 |
| 2025-09-05 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −100 | $21.00 | $2K | 44,041 |
| 2025-09-05 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −100 | 99,595 |
Page 6 of 11 · 210 trades